April 29, 2016 6:52 AM ET

Biotechnology

Company Overview of Amorcyte, LLC

Company Overview

Amorcyte, LLC develops and manufactures cell therapy products for the treatment of cardiovascular diseases. Its product includes AMR-001, a bone marrow-derived, CD34 positive selected stem cell product for the prevention of major adverse cardiac events following acute myocardial infarction. The company was incorporated in 2005 and is based in Allendale, New Jersey. As of October 17, 2011, Amorcyte, LLC operates as a subsidiary of Caladrius Biosciences, Inc.

4 Pearl Court

Suite C

Allendale, NJ 07401

United States

Founded in 2005

Phone:

201-883-1406

Fax:

201-883-1406

Key Executives for Amorcyte, LLC

Founder and Chief Scientific Officer
Age: 58
Chief Medical Officer and Managing Director
Senior Vice President of Corporate Development and Licensing
Consultant
Age: 83
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Genetics Institute, LLC United States
Rocky Mountain Biosystems, Inc. United States
Alice Therapeutics, Inc. United States
Melinta Therapeutics, Inc. United States
NanoCor Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Amorcyte, LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.